Source link : https://www.newshealth.biz/health-news/haip-chemo-offers-os-advantage-in-advanced-intrahepatic-cholangiocarcinoma/
SAN FRANCISCO — Hepatic arterial infusion pump (HAIP) chemotherapy with floxuridine significantly improved overall survival (OS) in patients with advanced intrahepatic cholangiocarcinoma (iCCA), according to results from a phase II study. Patients treated with HAIP chemotherapy combined with systemic chemotherapy achieved a 1-year OS of 80% compared with 47% in the historical cohort treated with […]
Author : News Health
Publish date : 2024-01-20 15:25:34
Copyright for syndicated content belongs to the linked Source.